Kenilworth NJ based Merck & Co. to spend $1 Billion to occupy 120,000 square feet of new space in Elkton Virginia.
Elkton, Virginia — According to state and local economic development sources Merck & Co Inc plans to invest $1 Billion to build out new space in Elkton. The company plans to occupy the new space on or about June 1, 2021. According to the company website Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
To learn more about Merck & Co Inc, visit http://www.merck.com/
Company Contact:
Sanat Chattopadhyay, Executive Vice President
https://www.linkedin.com/in/sanat-chattopadhyay/
SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved